(VIANEWS) – Shares of MAUNA KEA TECH (CAC 40: MKEA.PA) rose 9.67% to €0.64 at 14:00 EST on Thursday, following the last session’s downward trend. CAC 40 is sliding 0.48% to €7,289.82, after two successive sessions in a row of losses. This seems, so far, a somewhat bearish trend trading session today.
MAUNA KEA TECH’s last close was €0.58, 41.31% below its 52-week high of €0.99.
About MAUNA KEA TECH
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.418.
Volatility
MAUNA KEA TECH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a negative 0.80%, and a positive 3.15%.
MAUNA KEA TECH’s highest amplitude of average volatility was 2.44% (last week), 2.43% (last month), and 3.15% (last quarter).
Volume
Today’s last reported volume for MAUNA KEA TECH is 694699 which is 102.78% above its average volume of 342584.
More news about MAUNA KEA TECH (MKEA.PA).
